medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2018, Number 6

<< Back Next >>

Ann Hepatol 2018; 17 (6)

Association of Interleukin-6 and Interleukin-1 Family Gene Polymorphisms in Autoimmune Hepatitis

Yousefi A, Najafi M, Motamed F, Mahmoudi E, Zare BA, Sadr M, Rahmani F, Farhmand F, Khodadad A, Fallahi G, Rezaei N

Language: English
References: 37
Page: 1021-1025
PDF size: 138.75 Kb.


ABSTRACT

Introduction and aim. Autoimmune hepatitis (AIH) is an immune-mediated destruction of liver cells, in recognition of interface hepatitis, seropositivity for autoantibodies, and interface hepatitis in histology sections. Hepatocyte destruction in AIH is the direct result of CD4+ T-cell destruction. Yet, Th17 mediated immune attach and a diversity of cytokine networks, including pro-inflammatory cytokines such as Interleukin 1 (IL-1) and Interleukin 6 (IL-6), set the stage for the destructive liver damage. Material and method. Peripheral blood samples from 57 patients, with AIH, recruited from referrals to the main pediatric hospital in Tehran. Single nucleotide polymorphisms for the following cytokines genes, were evaluated through, polymerase chain reaction with sequencespecific primers (PCR-SSP) assay: IL-1a (C/T -889), IL-1α (C/T -511), IL-1β (C/T +3962), IL-1 receptor (IL-1R; C/T Pst-I 1970), IL-1RA (C/T Mspa-I 11100), and IL-6 (C/G -174 and A/G nt565). Results. Significant higher frequency of genotype AA was detected in patients in IL-6 at position nt565 (15.8% in AIH patients vs. 2.9% in controls, p = 0.003). The haplotype GA of IL-6 at -174 and nt565, was significantly overrepresented in the AIH group, compared to (20.9% of AIH vs. 1.4% in controls p ‹ 0.0001). Conclusion. Results of our study, indicate significant deviation toward high yield IL-6 polymorphisms, in AIH patients. These data could bring new insights in pathophysiology of disease, which could contribute to developing novel treatments for AIH.


REFERENCES

  1. Gossard AA, Lindor KD. Autoimmune hepatitis: a review. J Gastroenterol 2012: 47: 498-503. doi: 10.1007/s00535-012- 0586-z.

  2. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006: 354: 54-66. doi: 354/1/54 [pii] 10.1056/NEJMra050408.

  3. Obermayer-Straub P, Strassburg CP, Manns MP. Autoimmune hepatitis. J Hepatol 2000: 32: 181-97.

  4. Mieli-Vergani G, Vergani D. Autoimmune hepatitis in children: what is different from adult AIH? Semin Liver Dis 2009: 29: 297-306. doi: 10.1055/s-0029-1233529.

  5. Beland K, Lapierre P, Alvarez F. Influence of genes, sex, age and environment on the onset of autoimmune hepatitis. World J Gastroenterol 2009; 15: 1025-34.

  6. Wong RJ, Gish R, Frederick T, Bzowej N, Frenette C. The impact of race/ethnicity on the clinical epidemiology of autoimmune hepatitis. J Clin Gastroenterol 2012: 46: 155-61. doi: 10.1097/MCG.0b013e318228b781.

  7. Czaja AJ. Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis. Clin Gastroenterol Hepatol 2008; 6: 379-88. doi: 10.1016/ j.cgh.2007.12.048S1542-3565(07)01251-7 [pii].

  8. Vergani D, Mieli-Vergani G. Aetiopathogenesis of autoimmune hepatitis. World J Gastroenterol 2008; 14: 3306-12.

  9. Kahraman A, Gerken G, Canbay A. Apoptosis in immune-mediated liver diseases. Dig Dis 2010; 28: 144-9. doi: 10.1159/ 000299799000299799 [pii].

  10. Vierling JM. Autoimmune hepatitis and antigen-specific T regulatory cells: when can we send in the regulators? Hepatology 2011; 53: 385-8. doi: 10.1002/hep.24153.

  11. Santodomingo-Garzon T, Swain MG. Role of NKT cells in autoimmune liver disease. Autoimmun Rev 2011: 10: 793-800. doi: 10.1016/j.autrev.2011.06.003S1568-9972(11)00145-5 [pii].

  12. Zhao L, Tang Y, You Z, Wang Q, Liang S, Han X, Qiu D, et al. Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression. PLoS One 2011:6:e18909. doi: 10.1371/ journal.pone.0018909.

  13. Popko K, Gorska E, Demkow U. Influence of interleukin-6 and G174C polymorphism in IL-6 gene on obesity and energy balance. Eur J Med Res 2010:15 Suppl 2:123-7.

  14. Vasilyev FF, Silkov AN, Sennikov SV. Relationship between interleukin-1 type 1 and 2 receptor gene polymorphisms and the expression level of membrane-bound receptors. Cell Mol Immunol 2015; 12: 222-30. doi: 10.1038/cmi.2014.43.

  15. Amirzargar A, Shahram F, Nikoopour E, Rezaei N, Saeedfar K, Ziaei N, Davatchi F. Proinflammatory cytokine gene polymorphisms in Behcet’s disease. Eur Cytokine Netw 2010; 21: 292-6. doi: 10.1684/ecn.2009.0209.

  16. Barkhordari E, Rezaei N, Ansaripour B, Larki P, Alighardashi M, Ahmadi-Ashtiani HR, Mahmoudi M, et al. Proinflammatory cytokine gene polymorphisms in irritable bowel syndrome. J Clin Immunol 2010; 30: 74-9. doi: 10.1007/s10875-009- 9342-4.

  17. Rezaei N, Amirzargar AA, Shakiba Y, Mahmoudi M, Moradi B, Aghamohammadi A. Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency. Clin Exp Immunol 2009; 155: 21-7. doi: 10.1111/ j.1365-2249.2008.03790.x.

  18. Mahdaviani SA, Rezaei N, Moradi B, Dorkhosh S, Amirzargar AA, Movahedi M. Proinflammatory cytokine gene polymorphisms among Iranian patients with asthma. J Clin Immunol 2009; 29: 57-62. doi: 10.1007/s10875-008-9232-1.

  19. Amirzargar AA, Bagheri M, Ghavamzadeh A, Alimoghadam K, Khosravi F, Rezaei N, Moheydin M, et al. Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukaemia. Int J Immunogenet 2005; 32: 167-71. doi: 10.1111/j.1744-313X.2005.00502.x.

  20. Amirzargar AA, Rezaei N, Jabbari H, Danesh AA, Khosravi F, Hajabdolbaghi M, Yalda A, et al. Cytokine single nucleotide polymorphisms in Iranian patients with pulmonary tuberculosis. Eur Cytokine Netw 2006; 17: 84-9.

  21. Fan LY, Tu XQ, Zhu Y, Pfeiffer T, Feltens R, Stoecker W, Zhong RQ. Genetic association of cytokines polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. World J Gastroenterol 2005; 11: 2768-72.

  22. Assari R, Aghighi Y, Ziaee V, Sadr M, Rezaei A, Rahmani F, Sadr Z, et al. Interleukin-4 cytokine single nucleotide polymorphisms in kawasaki disease: A case-control study and a review of knowledge. Internat J Rheumat Dis 2016. doi: 10.1111/1756-185X.12968.

  23. Assari R, Aghighi Y, Ziaee V, Sadr M, Rahmani F, Rezaei A, Sadr Z, et al. Pro-inflammatory cytokine single nucleotide polymorphisms in Kawasaki disease. Internat J Rheumat Diseases 2016. doi: 10.1111/1756-185X.12911.

  24. Eskandari V, Amirzargar AA, Mahmoudi MJ, Rahnemoon Z, Rahmani F, Sadati S, Rahmati Z, et al. Gene expression and levels of IL-6 and TNF alpha in PBMCs correlate with severity and functional class in patients with chronic heart failure. Ir J Med Sci 2017. doi: 10.1007/s11845-017-1680-2.

  25. Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, Bittencourt PL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48: 169- 76. doi: 10.1002/hep.22322.

  26. Amirzargar AA, Naroueynejad M, Khosravi F, Dianat SS, Rezaei N, Mytilineos J, Nikbin B, et al. Cytokine single nucleotide polymorphisms in Iranian populations. Eur Cytokine Netw 2008; 19: 104-12. doi: 10.1684/ecn.2008.0122.

  27. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.

  28. Muratori L, Longhi MS. The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies. J Autoimmun 2013; 46: 74-80. doi: 10.1016/j.jaut.2013.06.016.

  29. Liberal R, Vergani D, Mieli-Vergani G. Update on Autoimmune Hepatitis. J Clin Transl Hepatol 2015; 3: 42-52. doi: 10.14218/jcth.2014.00032.

  30. Thomas-Dupont P, Remes-Troche JM, Izaguirre-Hernández IY, Sánchez-Vargas LA, Maldonado-Rentería M de J, Hernández-Flores KG, Torre A, et al. Elevated circulating levels of IL-21 and IL-22 define a cytokine signature profile in type 2 autoimmune hepatitis patients. Ann Hepatol 2016: 15: 550-8.

  31. Maggiore G, De Benedetti F, Massa M, Pignatti P, Martini A. Circulating levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in children with autoimmune hepatitis. J Pediatr Gastroenterol Nutr 1995: 20: 23-7.

  32. Bostrom EA, Ekstedt M, Kechagias S, Sjowall C, Bokarewa MI, Almer S. Resistin is associated with breach of tolerance and anti-nuclear antibodies in patients with hepatobiliary inflammation. Scand J Immunol 2011; 74: 463-70. doi: 10.1111/j.1365-3083.2011.02592.x.

  33. Cookson S, Constantini PK, Clare M, Underhill JA, Bernal W, Czaja AJ, Donaldson PT, et al. Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology 1999; 30: 851-6. doi: S0270913999004310 [pii]10.1002/hep.510300412.

  34. al-Wabel A, al-Janadi M, Raziuddin S. Cytokine profile of viral and autoimmune chronic active hepatitis. J Allergy Clin Immunol 1993; 92: 902-8. doi: 0091-6749(93)90068-Q [pii].

  35. Stoica AL, Stoica E, Constantinescu I, Uscatescu V, Ginghina C. Interleukin-6 and interleukin-10 gene polymorphism, endothelial dysfunction, and postoperative prognosis in patients with peripheral arterial disease. J Vasc Surg 2010; 52: 103-9. doi: 10.1016/j.jvs.2010.01.088.

  36. Aureli A, Sebastiani P, Del Beato T, Marimpietri AE, Graziani A, Sechi E, Di Loreto S, et al. Involvement of IL-6 and IL-1 receptor antagonist on intellectual disability. Immunol Lett 2014; 162: 124-31. doi: 10.1016/j.imlet.2014.08.003.

  37. Movahedi M, Tavakol M, Rahmani F, Amirzargare AA, Bidokie AZ, Heidari K, Gharagozlou M, et al. Interleukin-6 and tumor necrosis factor-alpha gene polymorphisms in chronic idiopathic urticaria. Allergol Immunopathol (Madr) 2014; 42: 533-8. doi: 10.1016/j.aller.2013.06.004.




2020     |     www.medigraphic.com